{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-23-000356","form_type":"8-K","ticker":"ARCT","cik":"0001768224","company_name":"Arcturus Therapeutics Holdings Inc.","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.466786+00:00","generated_at":"2026-06-17T23:39:44.900109+00:00","sec_items":["1.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Arcturus terminates $15M Western Alliance loan with $7.36M payoff, releases liens","bullets":["Paid ~$7.36M from cash on hand to terminate Western Alliance Bank loan agreement on March 14, 2023.","Loan originally up to $15M with floating rate prime+1.25-2.75% and maturity October 30, 2023.","Payoff includes ~$7.02M principal/interest, $300K prepayment fee tied to prior FDA IND approval, and $35K prepayment charges.","All liens under the Western Alliance Agreement have been released."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-23-000356","json":"https://secwatch.observer/filing/0001193805-23-000356.json","markdown":"https://secwatch.observer/filing/0001193805-23-000356.md","text":"https://secwatch.observer/filing/0001193805-23-000356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523000356/0001193805-23-000356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523000356/e618370_8k-arct.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:39:44.900109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12478c97c20727ccbc33226d295ee0aa6ebb7178","claim":"Arcturus Therapeutics Holdings Inc. terminated Western Alliance Agreement with Western Alliance Bank valued at approximately $7.36 million (effective 2023-03-14).","evidence_excerpt":"On March 14, 2023, the Loan and Security Agreement, dated as of October 12, 2018 (as amended and supplemented, the “Western Alliance Agreement”) by and between Arcturus Therapeutics, Inc. (“Arcturus Therapeutics”), a wholly-owned subsidiary of Arcturus Therapeutics Holdings, Inc. (the “Company” and together with Arcturus Therapeutics, “Arcturus”), and Western Alliance Bank, an Arizona corporation (“Western Alliance”), was terminated (the “Termination”) upon the receipt by Western Alliance of a payoff amount of approximately $7.36 million from Arcturus.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1768224/000119380523000356/0001193805-23-000356-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Western Alliance Bank"},{"label":"Value","value":"approximately $7.36 million"},{"label":"Effective","value":"2023-03-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}